Skip to Main Content

CTSA Initiatives

Yale, in partnership with our community allies and the FDA Office of Minority Health and Health Equity, is driving forward initiatives to promote racial equity in clinical trials through community engagement and empowerment. For over a decade, under the leadership of the CTSA, the Yale Center for Clinical Investigation (YCCI) and our Cultural Ambassadors have championed efforts to enhance diverse participation in clinical trials and address critical health disparities. By working alongside the FDA and local communities, we bridge the gap between researchers and patients—the vital participants in clinical research—and strive to ensure that these partnerships become a cornerstone of our work at YCCI.

Our commitment to advancing clinical and translational science extends beyond diversity. YCCI’s initiatives align closely with the core priorities of the CTSA program, which include:

  • Innovative Solutions in Clinical Research: We develop, test, and share novel scientific and operational methods that improve the entire clinical research process—from the discovery phase, through first-in-human trials, to medical implementation and widespread community adoption.
  • Collaborative Networks: We foster strategic partnerships at local, regional, and national levels, accelerating translational research efforts and enhancing the delivery of scientific discoveries to real-world practice.
  • Addressing Health Disparities: Our innovative programs connect institutions and communities in collaborative efforts to address health disparities, ensuring that the benefits of clinical research reach underserved populations.
  • Improving Research Quality and Safety: YCCI is at the forefront of creating and applying scientific and operational improvements that elevate the safety, quality, and efficiency of clinical trials, driving more effective and informative research outcomes.
  • Public Health Responsiveness: We stand as a national resource, capable of mobilizing rapidly in response to public health crises and urgent medical needs, contributing essential insights and resources when time is critical.

Through these efforts, YCCI continues to transform the landscape of clinical trials and translational research, ensuring that every community has a role in shaping the future of healthcare. Learn more about our partnership with the FDA, the importance of inclusive participation in clinical research, and how you can contribute to the discoveries that will shape tomorrow's medical breakthroughs.

Help Us Discover.